Cargando…
Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much resea...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711672/ https://www.ncbi.nlm.nih.gov/pubmed/33212878 http://dx.doi.org/10.3390/toxics8040105 |
_version_ | 1783618198149529600 |
---|---|
author | Górna, Ilona Napierala, Marta Florek, Ewa |
author_facet | Górna, Ilona Napierala, Marta Florek, Ewa |
author_sort | Górna, Ilona |
collection | PubMed |
description | The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on the level of concentration of total cholesterol, LDL fraction, and HDL fraction differed. In most cases, e-cigarettes use increased the risk of developing abdominal obesity or higher arterial blood pressure. Further research is required to provide more evidence on this topic. |
format | Online Article Text |
id | pubmed-7711672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77116722020-12-04 Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review Górna, Ilona Napierala, Marta Florek, Ewa Toxics Review The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on the level of concentration of total cholesterol, LDL fraction, and HDL fraction differed. In most cases, e-cigarettes use increased the risk of developing abdominal obesity or higher arterial blood pressure. Further research is required to provide more evidence on this topic. MDPI 2020-11-17 /pmc/articles/PMC7711672/ /pubmed/33212878 http://dx.doi.org/10.3390/toxics8040105 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Górna, Ilona Napierala, Marta Florek, Ewa Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review |
title | Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review |
title_full | Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review |
title_fullStr | Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review |
title_full_unstemmed | Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review |
title_short | Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review |
title_sort | electronic cigarette use and metabolic syndrome development: a critical review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711672/ https://www.ncbi.nlm.nih.gov/pubmed/33212878 http://dx.doi.org/10.3390/toxics8040105 |
work_keys_str_mv | AT gornailona electroniccigaretteuseandmetabolicsyndromedevelopmentacriticalreview AT napieralamarta electroniccigaretteuseandmetabolicsyndromedevelopmentacriticalreview AT florekewa electroniccigaretteuseandmetabolicsyndromedevelopmentacriticalreview |